Isavuconazole: Difference between revisions
From IDWiki
(Created page with "== Dosing == * Isavuconazole 200 mg IV tid for 6 doses followed by 200 mg IV daily Category:Triazoles") Â |
(→â€)  |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | == |
+ | == Background == |
+ | === Mechanism of Action === |
||
⚫ | |||
+ | |||
+ | * Azole antifungal that inhibits lanosterol 14-α demethylase in the peptidoglycan synthesis pathway |
||
+ | |||
+ | === Spectrum of Activity === |
||
+ | |||
+ | *Active against [[Candida]], [[Cryptococcus]], [[Aspergillus]] including [[Aspergillus flavus]], [[Aspergillus fumigatus]], and [[Aspergillus niger]], and [[Mucorales]] |
||
+ | *Indications include {{#ask: [[Is treated by::isavuconazole]]}} |
||
+ | |||
+ | ==Dosing== |
||
+ | |||
⚫ | |||
+ | |||
+ | === Renal Dosing === |
||
+ | |||
+ | * No adjustment needed |
||
+ | |||
+ | === Hepatic Dosing === |
||
+ | |||
+ | * No adjustment needed |
||
+ | |||
+ | == Safety == |
||
+ | |||
+ | === Adverse Drug Reactions === |
||
+ | |||
+ | * Nausea, vomiting, diarrhea |
||
+ | * Elevated liver enzymes |
||
+ | **Generally transient ALT elevation that does not require change in therapy |
||
+ | **May also include severe cholestatic or hepatocellular enzyme rises within the first few months of therapy |
||
+ | **See also [https://www.ncbi.nlm.nih.gov/books/NBK548643/ LiverTox] |
||
+ | * Hypokalemia |
||
+ | |||
+ | === Drug-Drug Interactions === |
||
+ | |||
+ | * Increases levels of [[sirolimus]] and [[tacrolimus]] |
||
+ | * Increases levels of [[cyclosporine]] |
||
+ | * Contraindicated with [[carbamazepine]] |
||
[[Category:Triazoles]] |
[[Category:Triazoles]] |
Latest revision as of 09:23, 30 March 2022
Background
Mechanism of Action
- Azole antifungal that inhibits lanosterol 14-α demethylase in the peptidoglycan synthesis pathway
Spectrum of Activity
- Active against Candida, Cryptococcus, Aspergillus including Aspergillus flavus, Aspergillus fumigatus, and Aspergillus niger, and Mucorales
- Indications include Chromoblastomycosis, Cladophialophora, Coccidioides immitis
Dosing
- Isavuconazole 200 mg IV tid for 6 doses followed by 200 mg IV daily
Renal Dosing
- No adjustment needed
Hepatic Dosing
- No adjustment needed
Safety
Adverse Drug Reactions
- Nausea, vomiting, diarrhea
- Elevated liver enzymes
- Generally transient ALT elevation that does not require change in therapy
- May also include severe cholestatic or hepatocellular enzyme rises within the first few months of therapy
- See also LiverTox
- Hypokalemia
Drug-Drug Interactions
- Increases levels of sirolimus and tacrolimus
- Increases levels of cyclosporine
- Contraindicated with carbamazepine